CBD: no risk to public health or abuse according to WHO
Consumption of the cannabidiol (CBD), a cannabinoid naturally produced by cannabis, is safe, well tolerated, and poses no risk to public health, according to the preliminary report of the World Health Organization (WHO) Expert Committee on Drug Dependence.
The authors of the report also state that CBD «has no potential for abuse» and does not lead to physical dependence. «CBD is generally well tolerated and has a good safety profile.».
Concerning therapeutic effects of CBD, the WHO reports that it «has been shown to be an effective treatment for epilepsy» and that there is «preliminary evidence that CBD may be a useful treatment for a number of other conditions,» including Alzheimer’s, cancer, Parkinson’s disease, and psychosis.
While the report notes that «unregulated medical use of CBD» in oils or extracts is relatively common, it states that «there is no evidence of recreational use of CBD or of health problems associated with the use of pure CBD.»
The WHO is currently considering investing in CBD on international lists of controlled substances. Following the review, which is expected to take place in May 2018, the use of CBD could be restricted—as THC is today—and limited to the medical sector.
The «cannabis» fine raised to 500 euros under the RIPOST Act
Sacha Baron Cohen Brings Ali G Back to Life During a Surprise Appearance at Wimbledon
Botswana Paves the Way for Commercial Hemp Cultivation
The First Authorized Medical Cannabis Cultivation in the Canary Islands
Germany Ends Public Health Insurance Coverage for Medical Cannabis Flowers
Cannabis Legalization in Pennsylvania Once Again on Hold
Democratic senators are reviving a bill to legalize cannabis at the federal level in the United States
A THC:CBD oil shows promising results in reducing agitation in people with dementia
San Francisco Allows «Cannabis Cafés»
Kenya Denies Rastafarians the Right to Use Cannabis
-
Cannabis in Europe4 weeks agoBosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France4 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange
-
Cannabis in Africa2 weeks ago
Kenya Denies Rastafarians the Right to Use Cannabis
You must be logged in to post a comment Login